Insider trades
Francis Richard D., CEO of Teva Pharmaceutical Industries TEVA, has filed 0 purchases and 14 sales on the open market. Over the past 12 months that comes to a net sale of $31.3M. The latest trade was on 06/05.
Francis Richard D.
President and CEO
- First filing
- 23/02/17
- Trades
- 50 trades
- Buys / sales
- 0 / 14
- 12-month net buying
- −$31.3M
- Last trade
- 06/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/05 | 06/08 | 6,153 sh | $34.35 | $211,355.55 | −0.5% | |
| Open-market sale10b5-1 plan | 03/05 | 03/09 | 20,025 sh | $31.67 | $634,191.75 | −1.7% | |
| Open-market sale10b5-1 plan | 03/04 | 03/06 | 23,393 sh | $32.46 | $759,336.78 | −2.0% | |
TEVA | Open-market sale10b5-1 plan | 03/03 | 03/05 | 442,935 sh2 trades | $32.36avg. | $14,333,376.6 | −28.3% |
TEVA | Open-market sale10b5-1 plan | 02/15 | 02/18 | 447,778 sh2 trades | $34.22avg. | $15,322,963.16 | −42.5% |
TEVA | Open-market sale10b5-1 plan | 25/03/04–25/03/05 | 25/03/06 | 23,773 sh2 trades | $15.79avg. | $375,435.91 | −8.0% |
TEVA | Open-market sale10b5-1 plan | 25/03/03–25/03/04 | 25/03/05 | 31,342 sh2 trades | $16.06avg. | $503,363.48 | −11.3% |
| Open-market sale10b5-1 plan | 25/02/18 | 25/02/19 | 75,506 sh | $16.95 | $1,279,826.7 | −26.5% | |
| Open-market sale10b5-1 plan | 24/03/04 | 24/03/05 | 31,061 sh | $13.34 | $414,353.74 | −20.1% | |
| Open-market sale10b5-1 plan | 24/02/15 | 24/02/20 | 74,530 sh | $13.15 | $980,069.5 | −46.1% |